Amanda Gibbs

New England Journal of Medicine publishes long-term results of Gleevec® for patients with chronic myeloid leukemia

Study followed 1,106 patients around the world for more than 10 years

Mar 8, 2017

Study finds first evidence that PD-1 antibody could help men with metastatic prostate cancer

Jul 13, 2016

OHSU breaks new ground in cancer research

The 320,000 square foot Knight Cancer Institute research building will house up to 600 researchers, administrators dedicated to cancer research

Jun 16, 2016

Community to celebrate OHSU Knight Cancer Institute research building groundbreaking

Jun 15, 2016

OHSU Knight Cancer Institute funds 13 cancer research projects statewide

Jun 9, 2016

Nanotechnology expert selected to lead OHSU's large-scale early cancer detection initiative

Sadik Esener, Ph.D., will help launch the OHSU Knight Cancer Institute's recruitment of 20 to 30 top scientists and their research teams

Mar 7, 2016

Uncovering the financial ties of advocates for cancer drug approval

Feb 4, 2016

OHSU Knight Cancer Institute awards funding to 13 community health projects statewide

Funded projects ― which range from identifying barriers Oregonians face in quitting tobacco use to an after-school physical activity program for youth in rural communities ― are geared toward decreasing the state's cancer burden

Nov 30, 2015

Media's Frequent Use of Superlative Terms to Describe New Cancer Drugs Questioned by Study

While most new cancer drugs afford modest benefits, approved drugs or those in development may be heralded as "game changers” or "breakthroughs” in the lay press

Oct 30, 2015